Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer. [ 5 ] [ 6 ] [ 10 ] Dostarlimab is a …
Dostarlimab Uses, Side Effects & Warnings - Drugs.com
Jun 11, 2024 · Dostarlimab is used to treat adults with certain cancers after other treatments did not work or stopped working, and/or the cancer has returned, or it has spread or cannot be …
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mar 27, 2023 · Dostarlimab is an immune-checkpoint inhibitor that targets the programmed cell death 1 receptor. The combination of chemotherapy and immunotherapy may have synergistic …
Dostarlimab: The miracle drug for the treatment of colorectal …
Dostarlimab is an antibody to anti-programmed cell death receptor-1 (PD-1) which is used for the treatment of adults with mismatch repair-deficient (dMMR) recurrent or advanced solid tumors …
FDA grants accelerated approval to dostarlimab-gxly for dMMR …
On August 17, 2021, the Food and Drug Administration granted accelerated approval to dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) for adult patients with mismatch repair …
Dostarlimab-gxly - NCI - National Cancer Institute
Dostarlimab-gxly is a type of drug called an immune checkpoint inhibitor (a type of immunotherapy). It is a monoclonal antibody that binds to the protein PD-1 on the surface of …
EC Treatment Option for Certain Patients | JEMPERLI (dostarlimab …
JEMPERLI is a medicine that may treat certain cancers by working with your immune system. JEMPERLI can cause your immune system to attack normal organs and tissues in any area of …
Dostarlimab-gxly (intravenous route) - Mayo Clinic
Dostarlimab-gxly is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or under the direct supervision of …
Dostarlimab (Jemperli®) - Macmillan Cancer Support
Dostarlimab (Jemperli®) is an immunotherapy drug. It may also be called a checkpoint inhibitor. It is best to read this information with our general information about immunotherapy drugs and …
Dostarlimab - Memorial Sloan Kettering Cancer Center
Dec 12, 2022 · What is this drug used for? It is used to treat endometrial cancer. It is used to treat certain solid tumors. What do I need to tell my doctor BEFORE I take this drug? If you are …
Dostarlimab - Wikipedia
Dostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer. [ 5 ] [ 6 ] [ 10 ] Dostarlimab is a …
Dostarlimab Uses, Side Effects & Warnings - Drugs.com
Jun 11, 2024 · Dostarlimab is used to treat adults with certain cancers after other treatments did not work or stopped working, and/or the cancer has returned, or it has spread or cannot be …
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mar 27, 2023 · Dostarlimab is an immune-checkpoint inhibitor that targets the programmed cell death 1 receptor. The combination of chemotherapy and immunotherapy may have synergistic …
Dostarlimab: The miracle drug for the treatment of colorectal …
Dostarlimab is an antibody to anti-programmed cell death receptor-1 (PD-1) which is used for the treatment of adults with mismatch repair-deficient (dMMR) recurrent or advanced solid tumors …
FDA grants accelerated approval to dostarlimab-gxly for dMMR …
On August 17, 2021, the Food and Drug Administration granted accelerated approval to dostarlimab-gxly (Jemperli, GlaxoSmithKline LLC) for adult patients with mismatch repair …
Dostarlimab-gxly - NCI - National Cancer Institute
Dostarlimab-gxly is a type of drug called an immune checkpoint inhibitor (a type of immunotherapy). It is a monoclonal antibody that binds to the protein PD-1 on the surface of …
EC Treatment Option for Certain Patients | JEMPERLI (dostarlimab …
JEMPERLI is a medicine that may treat certain cancers by working with your immune system. JEMPERLI can cause your immune system to attack normal organs and tissues in any area of …
Dostarlimab-gxly (intravenous route) - Mayo Clinic
Dostarlimab-gxly is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or under the direct supervision of …
Dostarlimab (Jemperli®) - Macmillan Cancer Support
Dostarlimab (Jemperli®) is an immunotherapy drug. It may also be called a checkpoint inhibitor. It is best to read this information with our general information about immunotherapy drugs and …
Dostarlimab - Memorial Sloan Kettering Cancer Center
Dec 12, 2022 · What is this drug used for? It is used to treat endometrial cancer. It is used to treat certain solid tumors. What do I need to tell my doctor BEFORE I take this drug? If you are …
